ALXA
Alexza Pharmaceuticals, Inc.
NasdaqCM
People also watch:BIODAFFYCYCCACURAEZS
0.940.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.94
Open0.00
Bid0.00 x
Ask0.00 x
52wk Range
Day's Range0.00 - 0.00
Volume0
Avg Vol (3m)0
As of 3:53 PM EDT. Market closed.
  • Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
    Capital Cube2 months ago

    Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016

    Click here to see latest analysisAlexza Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Alexza Pharmaceuticals, Inc. – DURECT Corporation, Aradigm Corporation, BioDelivery Sciences International, Inc., Titan Pharmaceuticals, Inc., Paratek Pharmaceuticals Inc, Vanda Pharmaceuticals Inc., Nektar Therapeutics, Teva Pharmaceutical Industries Limited Sponsored […] (Read more...) The post Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 appeared first on CapitalCube.

  • Zacks3 months ago

    Why is Alexza Pharmaceuticals (ALXA) Stock Soaring Today?

    On Tuesday, shares of pharmaceutical company Alexza Pharmaceuticals (ALXA) are soaring, up over 66% in afternoon trading after the company announced it has entered into a definitive agreement to be acquired by Spain-based Ferrer Pharma Inc.